Abstract
Advances in immunological monitoring provide the means to track tumor antigen-specific cytotoxic T-lymphocytes (CTL) in humans after adoptive transfer with greater specificity and sensitivity than before. Novel tools can be used not only to detect antigen-specific CTL, but also to evaluate the function and phenotype of individual T-cells. Peptide major histocompatibility complexes (MHC) class I multimeric complexes are proving invaluable as fluorescent reagents for tracking of antigen-specific T-cells. The multimeric complex is constructed of four synthetic and biotinylated peptide-loaded MHC molecules, which are linked by a fluorochrome-labeled streptavidin molecule. In contrast to “indirect” assays such as limiting dilution analysis (LDA) or 51Cr release assays requiring in vitro stimulation, this method allows direct monitoring of very low numbers of peptide-specific T-cells without the need for in vitro sensitization. By combining the use of multimers with anticytokine antibodies, a more detailed picture of the tracked T-cell can be obtained. This chapter summarizes the application of these protocols to monitor ex vivo the frequency and functional activity of tumor-specific CTL after adoptive transfer. Furthermore, it details potential problems interfering with correct staining and provides guidance for interpretation of results.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Walter, E. A., Greenberg, P. D., Gilbert, M. J., et al. (1995) Reconstitution of cellular immunity against cytomegalovirus in recipients of allogeneic bone marrow by transfer of T-cell clones from the donor. N. Engl. J. Med. 333, 1038–1044.
Papadopoulos, E. B., Ladanyi, M., Emanuel, D., et al. (1994) Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N. Engl. J. Med. 330, 1185–1191.
Rosenberg, S. A. (2001) Progress in human tumour immunology and immunotherapy. Nature 411, 380–384.
Oelke, M., Moehrle, U., Chen, J. L., et al. (2000) Generation and purification of CD8+ melan-A-specific cytotoxic T lymphocytes for adoptive transfer in tumor immunotherapy. Clin. Cancer Res. 6, 1997–2005.
Yee, C., Thompson, J. A., Roche, P., et al. (2000) Melanocyte destruction after antigen-specific immunotherapy of melanoma. Direct evidence of t cell-mediated vitiligo. J. Exp. Med. 192, 1637–1644.
Meidenbauer, N., Marienhagen, J., Laumer, M., et al. (2003) Survival and tumor localization of adoptively transferred Melan-A-specific T cells in melanoma patients. J. Immunol. 170, 2161–2169.
Altman, J. D., Moss, P. A. H., Goulder, P. J. R., et al. (1996) Phenotypic analysis of antigen-specific T lymphocytes. Science 274, 94–96.
Pittet, M. J., Zippelius, A., Speiser, D. E., et al. (2001) Ex vivo IFN-gamma secretion by circulating CD8 T lymphocytes: implications of a novel approach for T cell monitoring in infectious and malignant diseases. J. Immunol. 166, 7634–7640.
Appay, V. and Rowland-Jones, S. L. (2002) The assessment of antigen-specific CD8+T cells through the combination of MHC class I tetramer and intracellular staining. J. Immunol. Methods 268, 9–19.
Kwok, W. W., Ptacek, N. A., Liu, A. W., and Buckner, J. H. (2002) Use of class II tetram-ers for identification of CD4+T cells. J. Immunol. Methods 268, 71–81.
Hercend, T., Meuer, S., Brennan, A., et al. (1983) Identification of a clonally restricted 90 kD heterodimer on two human cloned natural killer cell lines. Its role in cytotoxic effector function. J. Exp. Med. 158, 1547–1560.
Mackensen, A., Carcelain, G., Viel, S., et al. (1994) Direct evidence to support the immuno-surveillance concept in a human regressive melanoma. J. Clin. Invest 93, 1397–1402.
Hoffmann, T. K., Donnenberg, V. S., Friebe-Hoffmann, U., et al. (2000) Competition of peptide-MHC class I tetrameric complexes with anti-CD3 provides evidence for specificity of peptide binding to the TCR complex. Cytometry 41, 321–328.
Meidenbauer, N., Hoffmann, T. K., and Donnenberg, A. D. (2003) Direct visualization of antigen-specific T cells using peptide-MHC-class I tetrameric complexes. Methods 31, 160–171.
Tan, R., Xu, X., Ogg, G. S., et al. (1999) Rapid death of adoptively transferred T cells in acquired immunodeficiency syndrome. Blood 93, 1506–1510.
Nielsen, M. B., Monsurro, V., Migueles, S. A., et al. (2000) Status of activation of circulatingvaccine-elicited CD8+T cells. J. Immunol. 165, 2287–2296.
Whelan, J. A., Dunbar, P. R., Price, D. A., et al. (1999) Specificity of CTL interactions with peptide-MHC class I tetrameric complexes is temperature dependent. J. Immunol. 163, 4342–4348.
Dutoit, V., Rubio-Godoy, V., Doucey, M. A., et al. (2002) Functional avidity of tumor antigen-specific CTL recognition directly correlates with the stability of MHC/peptide multimer binding to TCR. J. Immunol. 168, 1167–1171.
Denkberg, G., Cohen, C. J., and Reiter, Y. (2001) Critical role for CD8 in binding of MHC tetramers to TCR: CD8 antibodies block specific binding of human tumor-specific MHC-peptide tetramers to TCR. J. Immunol. 167, 270–276.
Hoffmann, T. K., Loftus, D. J., Nakano, K., et al. (2002) The ability of variant peptides to reverse the nonresponsiveness of T lymphocytes to the wild-type sequence p53(264-272) epitope. J. Immunol. 168, 1338–1347.
Xu, X. N. and Screaton, G. R. (2002) MHC/peptide tetramer-based studies of T cell function. J. Immunol. Methods 268, 21–28.
Knabel, M., Franz, T. J., Schiemann, M., et al. (2002) Reversible MHC multimer staining for functional isolation of T-cell populations and effective adoptive transfer. Nat. Med. 8, 631–637.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Humana Press Inc.
About this protocol
Cite this protocol
Meidenbauer, N., Mackensen, A. (2005). Tracking Adoptively Transferred Antigen-Specific T-Cells With Peptide/MHC Multimers. In: Ludewig, B., Hoffmann, M.W. (eds) Adoptive Immunotherapy: Methods and Protocols. Methods in Molecular Medicine™, vol 109. Humana Press. https://doi.org/10.1385/1-59259-862-5:185
Download citation
DOI: https://doi.org/10.1385/1-59259-862-5:185
Publisher Name: Humana Press
Print ISBN: 978-1-58829-406-7
Online ISBN: 978-1-59259-862-5
eBook Packages: Springer Protocols